Related Experiment Videos
Metronidazole in periodontitis: reduced need for surgery
W J Loesche1, J R Giordano, P Hujoel
1University of Michigan, School of Dentistry, Ann Arbor 48109-1078.
Journal of Clinical Periodontology
|February 1, 1992
Summary
Systemic metronidazole significantly reduced periodontal pocket depths and improved attachment levels, decreasing the need for surgery in periodontitis patients. This anaerobic infection treatment benefits patients beyond standard debridement alone.
Area of Science:
- Periodontology
- Microbiology
- Pharmacology
Background:
- Periodontitis is often linked to specific anaerobic bacterial species in subgingival plaque.
- Most periodontitis cases can be considered anaerobic infections.
Purpose of the Study:
- To evaluate the efficacy of systemic metronidazole as an adjunct to debridement in treating periodontitis.
- To assess the impact of metronidazole on clinical parameters and the need for periodontal surgery.
Main Methods:
- A double-blind, placebo-controlled study involving patients with elevated spirochete proportions in plaque.
- Patients received either metronidazole (250 mg 3x/day for 1 week) or placebo post-debridement.
- Clinical outcomes and microbial profiles were assessed 4-6 weeks later.
Main Results:
- Metronidazole group showed significant reduction in probing depth and gain in attachment levels compared to placebo.
- A notable decrease in the requirement for periodontal surgery was observed in the metronidazole group.
- Clinical improvements correlated with reduced proportions of spirochetes, selenomonads, motile rods, P. intermedius, and increased cocci.
Conclusions:
- Systemic metronidazole provides additional therapeutic benefits for periodontitis when administered after root surface debridement.
- Metronidazole treatment can reduce the need for periodontal surgery beyond the effects of debridement alone.
- This supports the role of metronidazole in managing anaerobic infections associated with periodontitis.